Abbott Will Gradually Quit the Infant and Children Nutrition Business in Mainland China

On December 14, 2022, US-based healthcare company Abbott announced that it will gradually quit the infant and children nutrition business in mainland China in 2023. In the recent two years, Abbott’s brand in terms of baby formulas has been negatively impacted by several scandals. However, the company also mentioned that it will operate its cross-border e-commerce platform to provide infant and children nutrition products across the globe. Abbott stressed that its other businesses in China, including diagnostic tools, medical equipment, and medicine, will not be impacted, and the company’s long-term investment in the Chinese market remains unchanged. (Source: stcn.com)

Visit HPA-China’s Information Hub, CLICK HERE